يعرض 1 - 10 نتائج من 50 نتيجة بحث عن '"Harms, A."', وقت الاستعلام: 0.63s تنقيح النتائج
  1. 1
    مؤتمر

    المؤلفون: Genet, A, Harms, LM, Leverkus, F

    المصدر: 65th Annual Meeting of the German Association for Medical Informatics, Biometry and Epidemiology (GMDS), Meeting of the Central European Network (CEN: German Region, Austro-Swiss Region and Polish Region) of the International Biometric Society (IBS); 20200906-20200909; Berlin; DOCAbstr. 273 /20210226/

    العلاقة: Ando Y, Coelho T, Berk JL, Cruz MW, Ericzon BG, Ikeda S, et al. Guideline of transthyretin-related hereditary amyloidosis for clinicians. Orphanet journal of rare diseases. 2013;8:31.; Blaser N, Vizcaya LS, Estill J, Zahnd C, Kalesan B, Egger M, et al. Gems: an R package for simulating from disease progression models. Journal of statistical software. 2015; 64(10): 1.; Rapezzi C, Quarta CC, Riva L, Longhi S, Gallelli I, Lorenzini M, et al. Transthyretin-related amyloidoses and the heart: a clinical overview. Nature reviews Cardiology. 2010;7(7):398-408.; Siepen FAD, Bauer R, Voss A, Hein S, Aurich M, Riffel J, et al. Predictors of survival stratification in patients with wild-type cardiac amyloidosis. Clinical research in cardiology : official journal of the German Cardiac Society. 2018;107(2):158-69.; http://dx.doi.org/10.3205/20gmds248Test; http://nbn-resolving.de/urn:nbn:de:0183-20gmds2482Test; http://www.egms.de/en/meetings/gmds2020/20gmds248.shtmlTest

  2. 2
    مؤتمر
  3. 3
    مؤتمر
  4. 4
    مؤتمر

    المؤلفون: Genet, A, Harms, LM, Leverkus, F

    المصدر: 19. Deutscher Kongress für Versorgungsforschung (DKVF); 20200930-20201001; sine loco [digital]; DOC20dkvf337 /20200925/

    مصطلحات موضوعية: ddc: 610

    العلاقة: Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C; ATTR-ACT Study Investigators. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. N Engl J Med. 2018 Sep;379(11):1007-1016. DOI:10.1056/NEJMoa1805689; Siepen FAD, Bauer R, Voss A, Hein S, Aurich M, Riffel J, Mereles D, Röcken C, Buss SJ, Katus HA, Kristen AV. Predictors of survival stratification in patients with wild-type cardiac amyloidosis. Clin Res Cardiol. 2018 Feb;107(2):158-169. DOI:10.1007/s00392-017-1167-1; http://dx.doi.org/10.3205/20dkvf337Test; http://nbn-resolving.de/urn:nbn:de:0183-20dkvf3370Test; http://www.egms.de/en/meetings/dkvf2020/20dkvf337.shtmlTest

  5. 5
    مؤتمر

    المصدر: 27. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie; 20201126-20201126; sine loco [digital]; DOC20gaa04 /20201123/

    مصطلحات موضوعية: ddc: 610

    العلاقة: Siepen FAD, Bauer R, Voss A, Hein S, Aurich M, Riffel J, et al. Predictors of survival stratification in patients with wild-type cardiac amyloidosis. Clin Res Cardiol. 2018;107(2):158-69.; http://dx.doi.org/10.3205/20gaa04Test; http://nbn-resolving.de/urn:nbn:de:0183-20gaa046Test; http://www.egms.de/en/meetings/gaa2020/20gaa04.shtmlTest

  6. 6
    مؤتمر
  7. 7
    مؤتمر
  8. 8
    مؤتمر
  9. 9
    مؤتمر
  10. 10
    مؤتمر